Emerald Mutual Fund Advisers Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $26M | Buy |
|
|||||
|
2023
Q1 | $23.2M | Sell |
|
|||||
|
2022
Q4 | $20M | Buy |
|
|||||
|
2022
Q3 | $11.1M | Buy |
|
|||||
|
2022
Q2 | $7.64M | Buy |
|
|||||
|
2022
Q1 | $7.14M | Buy |
|
|||||
|
2021
Q4 | $4.6M | Sell |
|
|||||
|
2021
Q3 | $28.3M | Buy |
|
|||||
|
2021
Q2 | $35.7M | Buy |
|
|||||
|
2021
Q1 | $25.1M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $8.99M | Sell |
|
|||||
|
2020
Q1 | $14.3M | Buy |
|
|||||
|
2019
Q4 | $20M | Sell |
|
|||||
|
2019
Q3 | $21.5M | Sell |
|
|||||
|
2019
Q2 | $34M | Hold |
|
|||||
|
2019
Q1 | $30.8M | Sell |
|
|||||
|
2018
Q4 | $27.3M | Buy |
|
|||||
|
2018
Q3 | $36.3M | Sell |
|
|||||
|
2018
Q2 | $17M | Buy |
|
|||||
|
2018
Q1 | $9.66M | Buy |
|
|||||
|
2017
Q4 | $13M | Sell |
|
|||||
|
2017
Q3 | $14.7M | Buy |
|
|||||
|
2017
Q2 | $9.3M | Buy |
|
|||||
|
2017
Q1 | $6.22M | Buy |
|
|||||
|
2016
Q4 | $5.01M | Buy |
|
|||||
|
2016
Q3 | $6.05M | Buy |
|
|||||
|
2016
Q2 | $3.6M | Buy |
|